Michael J. Englesbe

Michael J. Englesbe

Auto-generated profile, based on publicly available information

Michael J. Englesbe

Department of Surgery, Michigan Medicine

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
MEMichael J. Englesbe
Michael J. Englesbe
SPShaun P. Patel
Shaun P. Patel
KHKevin He
Kevin He
RLRaymond J. Lynch
Raymond J. Lynch
DSDouglas E. Schaubel
Douglas E. Schaubel
CSChristopher J. Sonnenday
Christopher J. Sonnenday
Surgeons frequently struggle to determine patient suitability for liver transplantation. Objective and comprehensive measures of overall burden of disease, such as sarcopenia, could inform clinicians and help avoid futile transplantations. The cross-sectional area of the psoas muscle was measured on CT scans of 163 liver transplant recipients. After controlling for donor and recipient characteristics using Cox regression models, we described the relationship between psoas area and post-transplantation mortality. Psoas area correlated poorly with Model for End-Stage Liver Disease score and serum albumin. Cox regression revealed a strong association between psoas area and post-transplantation mortality (hazard ratio = 3.7/1,000 mm(2) decrease in psoas area; p < 0.0001). When stratified into quartiles based on psoas area (holding donor and recipient characteristics constant), 1-year survival ranged from 49.7% for the quartile with the smallest psoas area to 87.0% for the quartile with the largest. Survival at 3 years among these groups was 26.4% and 77.2%, respectively. The impact of psoas area on survival exceeded that of all other covariates in these models. Central sarcopenia strongly correlates with mortality after liver transplantation. Such objective measures of patient frailty, such as sarcopenia, can inform clinical decision making and, potentially, allocation policy. Additional work is needed develop valid and clinically relevant measures of sarcopenia and frailty in liver transplantation.

1 March 2009 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
SKSachin Kheterpal
Sachin Kheterpal
KTKevin K. Tremper
Kevin K. Tremper
MHMichael Heung
Michael Heung
ARAndrew L. Rosenberg
Andrew L. Rosenberg
MEMichael Englesbe
Michael Englesbe
DCDarrell A. Campbell
Darrell A. Campbell
ACUTE kidney injury (AKI) after cardiac and vascular surgery has been well studied but remains a prevalent, devastating, and costly complication.1–5 Depending on the definition of AKI, it affects from 2% to 25% of cardiovascular surgery patients and increases the mortality and costs associated with these procedures by two to five times.1,3,6 Although more than 6 million general surgery procedures are performed each year in the United States,7 AKI in this group of patients has been largely unstudied.4 In a study of 15,000 patients without significant preexisting kidney dysfunction, Kheterpal et al. 8 recently demonstrated that approximately 1% of major noncardiac surgery procedures were complicated by AKI, defined as a significant reduction in calculated creatinine clearance to less than 50 ml/min.

1 December 2007 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
SKSachin Kheterpal
Sachin Kheterpal
KTKevin K. Tremper
Kevin K. Tremper
MEMichael J. Englesbe
Michael J. Englesbe
MOMichael O’reilly
Michael O’reilly
ASAmy M. Shanks
Amy M. Shanks
RSRichard D. Swartz
Richard D. Swartz
Background: The authors investigated the incidence and risk factors for postoperative acute renal failure after major noncardiac surgery among patients with previously normal renal function. Methods: Adult patients undergoing major noncardiac surgery with a preoperative calculated creatinine clearance of 80 ml/min or greater were included in a prospective, observational study at a single tertiary care university hospital. Patients were followed for the development of acute renal failure (defined as a calculated creatinine clearance of 50 ml/min or less) within the first 7 postoperative days. Patient preoperative characteristics and intraoperative anesthetic management were evaluated for associations with acute renal failure. Thirty-day, 60-day, and 1-yr all-cause mortality was also evaluated. Results: A total of 65,043 cases between 2003 and 2006 were reviewed. Of these, 15,102 patients met the inclusion criteria; 121 patients developed acute renal failure (0.8%), and 14 required renal replacement therapy (0.1%). Seven independent preoperative predictors were identified (P < 0.05): age, emergent surgery, liver disease, body mass index, high-risk surgery, peripheral vascular occlusive disease, and chronic obstructive pulmonary disease necessitating chronic bronchodilator therapy. Several intraoperative management variables were independent predictors of acute renal failure: total vasopressor dose administered, use of a vasopressor infusion, and diuretic administration. Acute renal failure was associated with increased 30-day, 60-day, and 1-yr all-cause mortality. Conclusions: Several preoperative predictors previously reported to be associated with acute renal failure after cardiac surgery were also found to be associated with acute renal failure after noncardiac surgery. The use of vasopressor and diuretics is also associated with acute renal failure.

6 August 2011 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MSMichael S. Sabel
Michael S. Sabel
JLJay Lee
Jay Lee
SCShijie Cai
Shijie Cai
MEMichael J. Englesbe
Michael J. Englesbe
SHStephen Holcombe
Stephen Holcombe
SWStewart Wang
Stewart Wang

1 December 2009 in Annals of Surgery
Verified
Journal Article
Closed access
RLRaymond J. Lynch
Raymond J. Lynch
DRDavid N. Ranney
David N. Ranney
CSCai Shijie
Cai Shijie
DLDennis S. Lee
Dennis S. Lee
NSNiharika Samala
Niharika Samala
MEMichael J. Englesbe
Michael J. Englesbe
We sought to understand whether obesity imparts detriment in outcome beyond risk of developing surgical site infection (SSI). Obesity is a risk factor for SSI following renal transplantation, and has been implicated in inferior patient and graft survival postoperatively. We conducted a retrospective review of all adult kidney-only transplants performed at the University of Michigan between September 2003 and April 2008. The primary exposure variable was recipient body mass index (BMI). Cox multivariable regression and Kaplan-Meier analysis were used to identify factors associated with SSI, graft loss, and patient death. In total, 869 recipients were studied, including 351 with BMI >30. Multivariate analysis revealed recipient age, delayed graft function, and BMI >30 to be independent risk factors for SSI. SSI was a significant risk factor for graft loss (HR: 2.194, 95% CI: 1.357-3.546) and approached significance as a risk factor for patient death (HR: 1.689, 95% CI: 0.941-3.028). Obesity had no independent effect on graft or patient outcome. SSI is associated with detriment to patient and graft survival following renal transplantation. The prevalence of SSI is higher among obese recipients, but those who avoid SSI have comparable outcomes to nonobese recipients. These findings redemonstrate the importance of SSI prevention following renal transplantation.

23 September 2013 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
RKRobert W. Krell
Robert W. Krell
DKDaniel R. Kaul
Daniel R. Kaul
AMAndrew R. Martin
Andrew R. Martin
MEMichael J. Englesbe
Michael J. Englesbe
CSChristopher J. Sonnenday
Christopher J. Sonnenday
PMPreeti N. Malani
Preeti N. Malani
Although sarcopenia (muscle loss) is associated with increased mortality after liver transplantation, its influence on other complications is less well understood. We examined the association between sarcopenia and the risk of severe posttransplant infections among adult liver transplant recipients. By calculating the total psoas area (TPA) on preoperative computed tomography scans, we assessed sarcopenia among 207 liver transplant recipients. The presence or absence of a severe posttransplant infection was determined by a review of the medical chart. The influence of posttransplant infections on overall survival was also assessed. We identified 196 episodes of severe infections among 111 patients. Fifty-six patients had more than 1 infection. The median time to the development of an infection was 27 days (interquartile range = 13-62 days). When the patients were grouped by TPA tertiles, patients in the lowest tertile had a greater than 4-fold higher chance of developing a severe infection in comparison with patients in the highest tertile (odds ratio = 4.6, 95% confidence interval = 2.25-9.53). In a multivariate analysis, recipient age (hazard ratio = 1.04, P = 0.02), pretransplant TPA (hazard ratio = 0.38, P < 0.01), and pretransplant total bilirubin level (hazard ratio = 1.05, P = 0.02) were independently associated with the risk of developing severe infections. Patients with severe posttransplant infections had worse 1-year survival than patients without infections (76% versus 92%, P = 0.003). In conclusion, among patients undergoing liver transplantation, a lower TPA was associated with a heightened risk for posttransplant infectious complications and mortality. Future efforts should focus on approaches for assessing and mitigating vulnerability in patients undergoing transplantation. Liver Transpl 19:1396–1402, 2013. © 2013 AASLD.